GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>If GTCB is as valuable as we think it is, why isn't anyone doing this or some other control deal? I think GTCB would accept even if it means voting on authorizing more shares available if needed. Imagine how much faster and more valuable GTCB would be with $170mm more in the bank!<

Insofar as GTC has multiple partners with disparate interests, I don’t think this is quite as simple as you make it seem. Moreover, there are change-of-control provisions in GTC’s agreement with LFB that might prove troublesome, although I haven’t studied them in detail. Still, I would not rule out the kind of scenario you describe.